Using DNA, radiation therapy gets personal

Elie Dolgin • September 23, 2016

Gene-based tests aim to predict who will benefit from radiation, or suffer.

At most cancer hospitals today, medical oncologists routinely order genetic tests that help guide their treatment decisions. If the tumor has a certain DNA mutation, the patient may be a good candidate for a targeted drug therapy; if it overexpresses a series of genes, chemotherapy might work well. But down the hallway in the radiation ward, cancer patients typically get a one-size-fits-all course of radiotherapy, regardless of their genetics or those of their cancer.


A small but increasing number of radiation oncologists is hoping to change that.


Continue reading at Science.

‘Connectoids’ use microfluid channels to recapitulate and study neural connections.
By Elie Dolgin May 14, 2025
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Picture of scientist handling mRNA, Robert F. Kennedy Jr. and vaccine protesters.
By Elie Dolgin May 9, 2025
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.